Ann Wion, J.D.

Associate Chief Counsel for Drugs and Biologics

U.S. Food & Drug Administration

Bethesda, MD

WORKING GROUP PARTICIPANTS June 21–23, 1992

Frank Cano, Ph.D.2

Vice-President

Lederle-Praxis Biologicals

Pearl River, NY

Mary Lou Clements, M.D.

Professor and Head

Division of Vaccine Sciences

Johns Hopkins School of Hygiene and Public Health

Baltimore, MD

George Curlin, M.D.

Deputy Director

Division of Microbiology and Infectious Diseases

National Institute for Allergy and Infectious Diseases

Bethesda, MD

Ciro de Quadros, M.D.

Regional Advisor

Expanded Program on Immunization

Pan American Health Organization

Washington, DC

Michael Epstein, J.D.

Partner

Weil, Gotshal & Manges

New York, NY

Elaine Esber, M.D.

Associate Director

Center for Biologics Evaluation and Research

U.S. Food & Drug Administration

Bethesda, MD

Ronald W. Hansen, Ph.D.

Associate Dean for Academic Affairs

William E. Simon Graduate School of Business

University of Rochester

Rochester, NY

Kerri-Ann Jones, Ph.D.

Chief, Human Resources

Development, Energy and Private Sector

U.S. Agency for International Development

Washington, DC

David T. Karzon, M.D.

Professor

Vanderbilt University



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement